These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30695467)

  • 1. [Liver Cancer].
    Yamashita T; Kaneko S
    Rinsho Byori; 2016 Jul; 64(7):787-796. PubMed ID: 30695467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
    Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
    Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
    Kudo M
    Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy.
    Kudo M
    J Gastroenterol Hepatol; 2010 Mar; 25(3):439-52. PubMed ID: 20370723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
    Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
    Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
    Ricco G; Cavallone D; Cosma C; Caviglia GP; Oliveri F; Biasiolo A; Abate ML; Plebani M; Smedile A; Bonino F; Pontisso P; Brunetto MR
    Cancer Biomark; 2018 Feb; 21(3):603-612. PubMed ID: 29278878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression pattern analysis of hepatocellular carcinoma tumor markers in viral hepatitis B and C patients undergoing liver transplantation and resection.
    Ha TY; Hwang S; Kim KH; Lee YJ; Ahn CS; Moon DB; Song GW; Park KM; Kim N; Lee SG
    Transplant Proc; 2014 Apr; 46(3):888-93. PubMed ID: 24767373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Yoon YJ; Han KH; Kim DY
    Scand J Gastroenterol; 2009; 44(7):861-6. PubMed ID: 19391065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
    Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
    Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy.
    Eskens FA; van Erpecum KJ; de Jong KP; van Delden OM; Klumpen HJ; Verhoef C; Jansen PL; van den Bosch MA; Méndez Romero A; Verheij J; Bloemena E; de Man RA
    Neth J Med; 2014 Jul; 72(6):299-304. PubMed ID: 25319854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
    Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and therapeutic management of hepatocellular carcinoma.
    Bellissimo F; Pinzone MR; Cacopardo B; Nunnari G
    World J Gastroenterol; 2015 Nov; 21(42):12003-21. PubMed ID: 26576088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnostic approach to hepatocellular carcinoma].
    Schacherer D; Schoelmerich J; Zuber-Jerger I
    Z Gastroenterol; 2007 Oct; 45(10):1067-74. PubMed ID: 17924305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
    Yano Y; Yamashita F; Kuwaki K; Fukumori K; Kato O; Yamamoto H; Ando E; Tanaka M; Sata M
    Liver Int; 2006 Sep; 26(7):789-95. PubMed ID: 16911460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers.
    Rodríguez de Lope C; Reig M; Matilla A; Ferrer MT; Dueñas E; Mínguez B; F Castroagudín J; Ortiz I; Pascual S; Lledó JL; Gallego A; Arenas JI; Aracil C; Forne M; Muñoz C; Pons F; Sala M; Iñarrairaegui M; Martin-Llahi M; Andreu V; Garre C; Rendón P; Fuentes J; Crespo J; Rodríguez M; Bruix J; Varela M;
    Med Clin (Barc); 2017 Jul; 149(2):61-71. PubMed ID: 28279536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation for hepatocellular carcinoma.
    Lee SG; Moon DB
    Recent Results Cancer Res; 2013; 190():165-79. PubMed ID: 22941020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.
    Song PP; Xia JF; Inagaki Y; Hasegawa K; Sakamoto Y; Kokudo N; Tang W
    World J Gastroenterol; 2016 Jan; 22(1):262-74. PubMed ID: 26755875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.